GLORIA

GEOMAR Library Ocean Research Information Access

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
Document type
Years
  • 1
    ISSN: 1365-2958
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Biology , Medicine
    Notes: Within the capsule gene complex (cps) of Neisseria meningitidis B a 5.5 kb DNA fragment encodes proteins with strong homologies to enzymes of the lipopolysaccharide biosynthetic pathway of Salmonella typhimurium and Escherichia coli, GalE, RfbB, RfbC and RfbD. A meningococcal galE mutant expressed a truncated lipooligosaccharide (LOS), which terminated at the glucose residue between inner and outer core, and a second gaiE gene present outside the cps cluster was found to be transcriptionally and functionally inactive and, thus, unable to complement this defect. Because of the defect in the outer core, the LOS of the galE-defective meningococcal mutant was not sialylated. In contrast, carbohydrate analysis of the LOS of an rfb-defective meningococcal mutant revealed no difference from the LOS of the wild-type strain, suggesting that the rfb genes are inactive. This was supported by Northern blot analysis, which showed that expression of the rfb gene products was transcriptionally regulated. The inability of the meningococcal galE mutant, which cannot sialylate the LOS, allowed us to investigate the significance of LOS sialylation in relation to the presence of the polysialic acid capsule. Sialylated LOS, but not the polysialic acid capsule, is necessary to confer complete serum resistance on the meningococcus by inhibition of the alternative complement pathway.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1433-0458
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Ziel des Artikels ist es nicht, internistisch-onkologisches Lehrbuchwissen zu ersetzen, sondern für die klinische Routine eine Basisinformation zur Prophylaxe und Therapie unerwünschter Wirkungen einer zytostatischen Chemotherapie bei Kopf-Hals-Karzinomen zu geben. Hierzu werden im 1. Abschnitt generelle Empfehlungen zur Vermeidung unerwünschter Wirkungen im Umgang mit Zytostatika dargestellt. Im 2. Abschnitt soll auf die Besonderheiten der heute bei Kopf-Hals-Karzinomen zugelassenen Substanzen eingegangen werden mit entsprechenden substanzspezifischen Empfehlungen zur Prophylaxe und Therapie unerwünschter Wirkungen. Im 3. Abschnitt werden spezielle supportive Therapieverfahren zur Behandlung bzw- Vermeidung unerwünschter Wirkungen einer zytostatischen Chemotherapie abgehandelt, die unabhängig von der jeweiligen Substanz eingesetzt werden können.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...